Of even more interest, dogs receiving vinblastine and piroxicam together had the following tumor responses: 58 % partial remission, 33 % stable disease, and 8 % progressive disease with a median survival of 299 days (range 21 - 637 days). (vet.purdue.edu)
It is for the human drug vinblastine, which is now being tested for its effectiveness in lymphoma. (vetmed.auburn.edu)
Purpose of Study: Although vinblastine is commonly used in veterinary cancer therapy, most commonly for treating feline lymphoma, there is currently no information on how the drug is distributed and eliminated in these cats. (vetmed.ucdavis.edu)